Literature DB >> 18559546

DNA repair capacity and lung cancer risk in never smokers.

Olga Y Gorlova1, Shih-Feng Weng, Yiqun Zhang, Christopher I Amos, Margaret R Spitz, Qingyi Wei.   

Abstract

Besides secondhand smoke exposure, few other risk factors for lung cancer in lifetime never smokers have been identified. We present the estimates of lung cancer risk associated with suboptimal DNA repair capacity (DRC) measured by the host-cell reactivation assay in lifetime never smokers using data from 219 cases and 309 matched controls enrolled in a case-control study. Suboptimal DRC level (below the control median) conferred a significantly increased lung cancer risk in never smokers [odds ratio, 1.92; 95% confidence interval (95% CI), 1.3-2.9; P = 0.0024]. There was a 3.38-fold risk for individuals with DRC below the first quartile (95% CI, 1.8-6.3) compared with individuals with DRC above the third quartile. Secondhand smoke exposure in individuals with DRC below the control median was associated with a 3.81-fold risk of lung cancer (95% CI, 2.3-6.4). A 2.49-fold (95% CI, 1.1-5.6) risk was noted for the joint effects of lung cancer family history in first-degree relatives and suboptimal DRC. Relatives of probands (cases and controls) with lowest DRC (below the first quartile) were significantly more likely to be diagnosed with lung cancer (odds ratio, 2.69; 95% CI, 1.1-6.7) compared with relatives of probands with the most proficient DRC (above the third quartile). Relatives of probands with suboptimal (below the control median) versus proficient DRC also had an earlier age at diagnosis with lung cancer, although the only statistically significant difference was in female relatives (55.4 versus 67.7 years; P = 0.03).

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18559546      PMCID: PMC6587178          DOI: 10.1158/1055-9965.EPI-07-2591

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  7 in total

1.  Evaluating the evidence for the relationship between passive smoking and lung cancer.

Authors:  Claire H Kim; Lina Mu; Ming Wu; Jin-Kou Zhao; Zuo-Feng Zhang
Journal:  Int J Cancer       Date:  2014-04-07       Impact factor: 7.396

2.  DNA Repair Capacity for Personalizing Risk and Treatment Response - Assay Development and Optimization in Human Peripheral Blood Mononuclear Cells (PBMCs).

Authors:  Nawar Al Nasrallah; Huaxin Zhou; Patricia A Smith; Catherine R Sears
Journal:  DNA Repair (Amst)       Date:  2022-01-19

3.  Estimation of the effects of smoking and DNA repair capacity on coefficients of a carcinogenesis model for lung cancer.

Authors:  Li Deng; Marek Kimmel; Millennia Foy; Margaret Spitz; Qingyi Wei; Olga Gorlova
Journal:  Int J Cancer       Date:  2009-05-01       Impact factor: 7.396

4.  Differential expression of DNA repair genes in Hispanic women with breast cancer.

Authors:  Jaime Matta; Luisa Morales; Julie Dutil; Manuel Bayona; Carolina Alvarez; Erick Suarez
Journal:  Mol Cancer Biol       Date:  2013-02-01

Review 5.  Association studies of ERCC1 polymorphisms with lung cancer susceptibility: a systematic review and meta-analysis.

Authors:  Jinhong Zhu; Rui-Xi Hua; Jing Jiang; Li-Qin Zhao; Xiuwei Sun; Jinwei Luan; Yaoguo Lang; Yanqi Sun; Kun Shang; Shiyun Peng; Jianqun Ma
Journal:  PLoS One       Date:  2014-05-19       Impact factor: 3.240

Review 6.  The potential of exploiting DNA-repair defects for optimizing lung cancer treatment.

Authors:  Sophie Postel-Vinay; Elsa Vanhecke; Ken A Olaussen; Christopher J Lord; Alan Ashworth; Jean-Charles Soria
Journal:  Nat Rev Clin Oncol       Date:  2012-02-14       Impact factor: 66.675

7.  Biochemical analysis of six genetic variants of error-prone human DNA polymerase ι involved in translesion DNA synthesis.

Authors:  Jinsook Kim; Insil Song; Ara Jo; Joo-Ho Shin; Hana Cho; Robert L Eoff; F Peter Guengerich; Jeong-Yun Choi
Journal:  Chem Res Toxicol       Date:  2014-09-09       Impact factor: 3.739

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.